Skip to main content

Measles cases are on the rise globally and here in Illinois the number is increasing as well. Vaccines are 97% effective in preventing this highly contagious disease.  To learn more about this infection and get information on vaccination, go to https://dph.illinois.gov/topics-services/diseases-and-conditions/diseases-a-z-list/measles.html.  Learn how to identify measles and the safe and effective vaccine that can prevent this potentially life-threatening infection for adults and children. 

About IDPH

Vaccination Equity for Prevention of Mpox

Download Vaccination Equity for Prevention of Mpox

In the United States the JYNNEOS vaccine has FDA approval for the prevention of mpox and smallpox. It can be given either via:

  • Subcutaneous (under the skin)
  • Intradermal (in between layers of the skin)

Both are equally effective and require getting a shot (usually in the arm). Unvaccinated people have a 14 times higher risk of monkeypox disease than those who got vaccinated.

Note: People with darker skin especially Black , Latino, or Asian people, and people ages 20 - 30 are more likely to develop keloid scars as a reaction to skin injury.

If individuals have had keloid scarring in the past or have concern they will have keloid scarring, JYNNEOS can be administered:

  • Subcutaneously

If you have concerns, you may discuss this with your provider or vaccinator.